Early effects of intravitreal anti-VEGF agents on cornea and visual acuity in patients with diabetic retinopathy

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi: 10.1016/S0140-6736(09)62124-3.
   PubMed Web of Science ®Google Scholar
• Browning DJ, Stewart MW, Lee C. Diabetic macular edema: evidence-based management. Indian J Ophthalmol. 2018;66(12):1736–1750. doi: 10.4103/ijo.IJO_1240_18.
   PubMed Web of Science ®Google Scholar
• Ferro Desideri L, Traverso CE, Nicolò M. An update on conbercept to treat wet age-related macular degeneration. Drug Today. 2020;56(5):311–320.
   PubMed Web of Science ®Google Scholar
• Gan L, Fagerholm P, Palmblad J. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand. 2004;82(5):557–563. doi: 10.1111/j.1600-0420.2004.00312.x.
   PubMedGoogle Scholar
• Guzel H, Bakbak B, Koylu MT, et al. The effect and safety of intravitreal injection of ranibizumab and bevacizumab on the corneal endothelium in the treatment of diabetic macular edema. Cutan Ocul Toxicol. 2017;36(1):5–8. doi: 10.3109/15569527.2016.1140177.
   PubMed Web of Science ®Google Scholar
• Rusovici R, Sakhalkar M, Chalam KV. Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Mol Vision. 2011;17:3339–3346.
   PubMed Web of Science ®Google Scholar
• Pacella E, Pacella F, La Torre G, et al. Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment. Clin Ter. 2012;163(6):e413-422–e422.
   Web of Science ®Google Scholar
• Bayar SA, Altinors DD, Kucukerdonmez C, et al. Severe corneal changes following intravitreal injection of bevacizumab. Ocul Immunol Inflamm. 2010;18(4):268–274. doi: 10.3109/09273948.2010.490630.
   PubMed Web of Science ®Google Scholar
• Skeie JM, Aldrich BT, Goldstein AS, et al. Proteomic analysis of corneal endothelial cell-descemet membrane tissues reveals influence of insulin dependence and disease severity in type 2 diabetes mellitus. PloS One. 2018;13(3):e0192287. doi: 10.1371/journal.pone.0192287.
   PubMed Web of Science ®Google Scholar
• Saini JS, Mittal S. In vivo assessment of corneal endothelial function in diabetes mellitus. Arch Ophthalmol. 1996;114(6):649–653. doi: 10.1001/archopht.1996.01100130641001.
   PubMedGoogle Scholar
• Bayhan HA, Aslan Bayhan S, Can I. Comparison of Central corneal thickness measurements with three new optical devices and a standard ultrasonic pachymeter. Int J Ophthalmol. 2014;7(2):302–308.
   PubMed Web of Science ®Google Scholar
• Módis L, Jr., Szalai E, Kertész K, et al. Evaluation of the corneal endothelium in patients with diabetes mellitus type I and II. Histol Histopathol. 2010;25(12):1531–1537.
   PubMed Web of Science ®Google Scholar
• Inoue K, Kato S, Inoue Y, et al. The corneal endothelium and thickness in type II diabetes mellitus. Jpn J Ophthalmol. 2002;46(1):65–69. doi: 10.1016/s0021-5155(01)00458-0.
   PubMed Web of Science ®Google Scholar
• Pont C, Ascaso FJ, Grzybowski A, et al. Corneal endothelial cell density during diabetes mellitus and ocular diabetes complications treatment. J Fr Ophtalmol. 2020;43(8):794–798. doi: 10.1016/j.jfo.2019.12.003.
   PubMed Web of Science ®Google Scholar
• Aldrich BT, Schlötzer-Schrehardt U, Skeie JM, et al. Mitochondrial and morphologic alterations in native human corneal endothelial cells associated with diabetes mellitus. Invest Ophthalmol Vis Sci. 2017;58(4):2130–2138. doi: 10.1167/iovs.16-21094.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhou Q, Li Z, et al. Hyperglycemia induces corneal endothelial dysfunction through attenuating mitophagy. Exp Eye Res. 2022;215:108903. doi: 10.1016/j.exer.2021.108903.
   PubMed Web of Science ®Google Scholar
• Omay E, Elgin U, Sen E, et al. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and Central corneal thickness. Int Ophthalmol. 2016;36(5):665–670. doi: 10.1007/s10792-016-0171-1.
   PubMed Web of Science ®Google Scholar
• Mathew PT, David S, Thomas N. Endothelial cell loss and Central corneal thickness in patients with and without diabetes after manual small incision cataract surgery. Cornea. 2011;30(4):424–428. doi: 10.1097/ICO.0b013e3181eadb4b.
   PubMed Web of Science ®Google Scholar
• Kang KH, Song MY, Kim KY, et al. Corneal endothelial cell changes after femtosecond Laser-Assisted cataract surgery in diabetic and nondiabetic patients. Eye Contact Lens. 2021;47(12):664–669. doi: 10.1097/ICL.0000000000000823.
   PubMed Web of Science ®Google Scholar
• Chancellor J, Soliman MK, Shoults CC, et al. Intraoperative complications and visual outcomes of cataract surgery in diabetes mellitus: a multicenter database study. Am J Ophthalmol. 2021;225:47–56. doi: 10.1016/j.ajo.2020.12.027.
   PubMed Web of Science ®Google Scholar
• Ziadi M, Moiroux P, d’Athis P, et al. Assessment of induced corneal hypoxia in diabetic patients. Cornea. 2002;21(5):453–457. doi: 10.1097/00003226-200207000-00004.
   PubMed Web of Science ®Google Scholar
• Santos AR, Santos T, Alves D, et al. Characterization of initial stages of diabetic macular edema. Ophthalmic Res. 2019;62(4):203–210. doi: 10.1159/000499117.
   PubMed Web of Science ®Google Scholar
• Fujiwara A, Kanzaki Y, Kimura S, et al. En face image-based classification of diabetic macular edema using swept source optical coherence tomography. Sci Rep. 2021;11(1):7665. doi: 10.1038/s41598-021-87440-3.
   PubMedGoogle Scholar
• Acan D, Calan M, Er D, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018;18(1):91. doi: 10.1186/s12886-018-0753-y.
   PubMed Web of Science ®Google Scholar
• Chatziralli I, Papadakou P, Dimitriou E, et al. The effect of intravitreal anti-vascular endothelial growth factor injections on corneal endothelium in patients with diabetic macular oedema. Cutan Ocul Toxicol. 2021;40(2):66–69. doi: 10.1080/15569527.2021.1887886.
   PubMed Web of Science ®Google Scholar
• Kuroiwa DAK, Malerbi FK, Regatieri CVS. New insights in resistant diabetic macular edema. Ophthalmologica. 2021;244(6):485–494. doi: 10.1159/000516614.
   PubMed Web of Science ®Google Scholar
• Nicholson L, Ramu J, Chan EW, et al. Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy. JAMA Ophthalmol. 2019;137(6):626–631. doi: 10.1001/jamaophthalmol.2019.0440.
   PubMed Web of Science ®Google Scholar
• Abdolrahimzadeh S, Gharbiya M, Formisano M, et al. Anti-Vascular endothelial growth factor intravitreal therapy and macular ganglion cell layer thickness in patients with neovascular age-related macular degeneration. Curr Eye Res. 2019;44(9):1000–1005. doi: 10.1080/02713683.2019.1610179.
   PubMed Web of Science ®Google Scholar
• Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. doi: 10.1186/s40662-015-0026-2.
   PubMedGoogle Scholar
• Trovato Battagliola E, Pacella F, Malvasi M, et al. Risk factors in central retinal vein occlusion: a multi-center case-control study conducted on the italian population: demographic, environmental, systemic, and ocular factors that increase the risk for major thrombotic events in the retinal venous system. Eur J Ophthalmol. 2022;32(5):2801–2809. doi: 10.1177/11206721211064469.
   PubMed Web of Science ®Google Scholar